Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2009, Article ID 535072, 11 pages
http://dx.doi.org/10.1155/2009/535072
Research Article

YQ36: A Novel Bisindolylmaleimide Analogue Induces KB/VCR Cell Death

Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China

Received 25 February 2009; Revised 22 May 2009; Accepted 15 October 2009

Academic Editor: Daniel T. Monaghan

Copyright © 2009 Ji Cao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. V. Ambudkar, S. Dey, C. A. Hrycyna, M. Ramachandra, I. Pastan, and M. M. Gottesman, “Biochemical, cellular, and pharmacological aspects of the multidrug transporter,” Annual Review of Pharmacology and Toxicology, vol. 39, pp. 361–398, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. R. Hipfner, R. G. Deeley, and S. P. C. Cole, “Structural, mechanistic and clinical aspects of MRP1,” Biochimica et Biophysica Acta, vol. 1461, no. 2, pp. 359–376, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Szakács, J. K. Paterson, J. A. Ludwig, C. Booth-Genthe, and M. M. Gottesman, “Targeting multidrug resistance in cancer,” Nature Reviews Drug Discovery, vol. 5, no. 3, pp. 219–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. H. T. Idriss, Y. A. Hannun, E. Boulpaep, and S. Basavappa, “Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say!,” Journal of Physiology, vol. 524, no. 3, pp. 629–636, 2000. View at Google Scholar · View at Scopus
  5. M. R. Jirousek, J. R. Gillig, C. M. Gonzalez et al., “(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16,2-dimetheno-1H,13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene- 1,3(2H)-dione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase Cß,” Journal of Medicinal Chemistry, vol. 39, no. 14, pp. 2664–2671, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Gekeler, R. Boer, F. Überall et al., “Effects of the selective bisindolylmaleimide protein kinase C inhibitor GP 109203X on P-glycoprotein-mediated multidrug resistance,” British Journal of Cancer, vol. 74, no. 6, pp. 897–905, 1996. View at Google Scholar · View at Scopus
  7. J. E. Merritt, J. A. Sullivan, L. Drew et al., “The bisindolylmaleimide protein kinase C inhibitor, Ro 32-2241, reverses multidrug resistance in KB tumour cells,” Cancer Chemotherapy and Pharmacology, vol. 43, no. 5, pp. 371–378, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Dusre, J. M. Covey, C. Collins, and B. K. Sinha, “DNA damage, cytotoxicity and free radical formation by mitomycin C in human cells,” Chemico-Biological Interactions, vol. 71, no. 1, pp. 63–78, 1989. View at Google Scholar · View at Scopus
  9. R. S. Tibbetts, K. M. Brumbaugh, J. M. Williams et al., “A role for ATR in the DNA damage-induced phosphorylation of p53,” Genes and Development, vol. 13, no. 2, pp. 152–157, 1999. View at Google Scholar · View at Scopus
  10. D. Xu, L. Fang, Q. Zhu, Y. Hu, Q. He, and B. Yang, “Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells,” Pharmazie, vol. 63, no. 7, pp. 528–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. H. J. Steinfelder, I. Quentin, and V. Ritz, “A fast and sensitive technique to study the kinetics and the concentration dependencies of DNA fragmentation during drug-induced apoptosis,” Journal of Pharmacological and Toxicological Methods, vol. 43, no. 1, pp. 79–84, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Ahmad, A. R. Safa, and R. I. Glazer, “Modulation of P-glycoprotein by protein kinase C α in a baculovirus expression system,” Biochemistry, vol. 33, no. 34, pp. 10313–10318, 1994. View at Google Scholar · View at Scopus
  13. S. P. Hardy, M. A. Valverde, H. R. Goodfellow, C. F. Higgins, and F. V. Sepúlveda, “Regulation of volume activated chloride channels by protein kinase C-mediated phosphorylation of P-glycoprotein,” Japanese Journal of Physiology, vol. 44, supplement 2, pp. S9–S15, 1994. View at Google Scholar · View at Scopus
  14. M. Schaich, S. Soucek, C. Thiede, G. Ehninger, and T. Illmer, “MDR1 and MRP1 gene expression are independent predictors for treatment outcome in adult acute myeloid leukaemia,” British Journal of Haematology, vol. 128, no. 3, pp. 324–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. S. B. Kaye, “Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention,” Current Opinion in Oncology, vol. 10, supplement 1, pp. S15–S19, 1998. View at Google Scholar · View at Scopus
  16. D. Mahadevan and A. F. List, “Targeting the multidrug resistance-1 transporter in AML: molecular regulation and therapeutic strategies,” Blood, vol. 104, no. 7, pp. 1940–1951, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Litman, T. Zeuthen, T. Skovsgaard et al., “Competitive, non-competitive and cooperative interactions between substrates of P-glycoprotein as measured by its ATPase activity,” Biochimica et Biophysica Acta, vol. 1361, no. 2, pp. 169–176, 1997. View at Google Scholar
  18. B. Pajak, S. Orzechowska, B. Gajkowska, and A. Orzechowski, “Bisindolylmaleimides in anti-cancer therapy—more than PKC inhibitors,” Advances in Medical Sciences, vol. 53, pp. 21–31, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Gekeler, R. Boer, F. Überall et al., “Effects of the selective bisindolylmaleimide protein kinase C inhibitor GP 109203X on P-glycoprotein-mediated multidrug resistance,” British Journal of Cancer, vol. 74, no. 6, pp. 897–905, 1996. View at Google Scholar · View at Scopus
  20. S. Desagher and J.-C. Martinou, “Mitochondria as the central control point of apoptosis,” Trends in Cell Biology, vol. 10, no. 9, pp. 369–377, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Kroemer and J. C. Reed, “Mitochondrial control of cell death,” Nature Medicine, vol. 6, no. 5, pp. 513–519, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Wang, “The expanding role of mitochondria in apoptosis,” Genes and Development, vol. 15, no. 22, pp. 2922–2933, 2001. View at Google Scholar · View at Scopus
  23. L. Naumovski, J. Ramos, M. Sirisawad et al., “Sapphyrins induce apoptosis in hematopoietic tumor-derived cell lines and show in vivo antitumor activity,” Molecular Cancer Therapeutics, vol. 4, no. 6, pp. 968–976, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. G. R. Devi, “XIAP as target for therapeutic apoptosis in prostate cancer,” Drug News and Perspectives, vol. 17, no. 2, pp. 127–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. C. L. Oliver, M. B. Miranda, S. Shangary, S. Land, S. Wang, and D. E. Johnson, “(−)-gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance,” Molecular Cancer Therapeutics, vol. 4, no. 1, pp. 23–31, 2005. View at Google Scholar · View at Scopus
  26. B. Yang and C. P. Reynolds, “Tirapazamine cytotoxicity for neuroblastoma is p53 dependent,” Clinical Cancer Research, vol. 11, no. 7, pp. 2774–2780, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Yamanaka, P. Rocchi, H. Miyake et al., “A novel antisense oligonucleotide inhibiting several antiapoptotic Bcl-2 family members induces apoptosis and enhances chemosensitivity in androgen-independent human prostate cancer PC3 cells,” Molecular Cancer Therapeutics, vol. 4, no. 11, pp. 1689–1698, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. F. A. Sinicrope and R. C. Penington, “Sulindac sulfide-induced apoptosis is enhanced by a small-molecule Bcl-2 inhibitor and by TRAIL in human colon cancer cells overexpressing Bcl-2,” Molecular Cancer Therapeutics, vol. 4, no. 10, pp. 1475–1483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. R. L. Hayward, J. S. Macpherson, J. Cummings, B. P. Monia, J. F. Smyth, and D. I. Jodrell, “Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: genetic evidence for specificity of the antisense effect,” Molecular Cancer Therapeutics, vol. 3, no. 2, pp. 169–178, 2004. View at Google Scholar · View at Scopus
  30. A. C. Childs, S. L. Phaneuf, A. J. Dirks, T. Phillips, and C. Leeuwenburgh, “Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio,” Cancer Research, vol. 62, no. 16, pp. 4592–4598, 2002. View at Google Scholar · View at Scopus
  31. M. A. Ortiz, F. J. Lopez-Hernandez, Y. Bayon, M. Pfahl, and F. J. Piedrafita, “Retinoid-related molecules induce cytochrome c release and apoptosis through activation of c-Jun NH2-terminal kinase/p38 mitogen-activated protein kinases,” Cancer Research, vol. 61, no. 23, pp. 8504–8512, 2001. View at Google Scholar · View at Scopus
  32. N. Miyoshi, K. Uchida, T. Osawa, and Y. Nakamura, “A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation,” Cancer Research, vol. 64, no. 6, pp. 2134–2142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Notarbartolo, M. Cervello, P. Poma et al., “Expression of the IAPs in multidrug resistant tumor cells,” Oncology Reports, vol. 11, no. 1, pp. 133–136, 2004. View at Google Scholar
  34. I. Tamm, S. M. Kornblau, H. Segall et al., “Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias,” Clinical Cancer Research, vol. 6, no. 5, pp. 1796–1803, 2000. View at Google Scholar · View at Scopus
  35. C. Du, M. Fang, Y. Li, L. Li, and X. Wang, “Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition,” Cell, vol. 102, no. 1, pp. 33–42, 2000. View at Google Scholar · View at Scopus
  36. A. M. Verhagen, P. G. Ekert, M. Pakusch et al., “Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins,” Cell, vol. 102, no. 1, pp. 43–53, 2000. View at Google Scholar · View at Scopus
  37. S.-Y. Shieh, M. Ikeda, Y. Taya, and C. Prives, “DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2,” Cell, vol. 91, no. 3, pp. 325–334, 1997. View at Publisher · View at Google Scholar · View at Scopus